1. FAK as a Target for Therapy in Head and Neck Cancer
   Nassim Khosravi et al, 2018, Molecular Determinants of Head and Neck Cancer CrossRef
2. RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation
   Pingfeng Chen et al, 2021, Cancer Immunology, Immunotherapy CrossRef
3. Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis
   Martin Del Castillo Velasco‐Herrera et al, 2018, Molecular Oncology CrossRef
4. Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck
   Aarti Bhatia et al, 2017, Cancers CrossRef
5. Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer
   Xiangdong Zhu et al, 2018, Cancers CrossRef
6. Pyk2 promotes tumor progression in renal cell carcinoma
   Tangliang Zhao et al, 2018, Oncology Letters CrossRef
7. C-C Chemokine Receptor 7 in Cancer
   Colin A. Bill et al, 2022, Cells CrossRef
8. EGFR signaling pathway occupies an important position in cancer‐related downstream signaling pathways of Pyk2
   Ting Shen et al, 2020, Cell Biology International CrossRef